Summary
42.70 -0.12(-0.28%)09/13/2024
Acme United Corp. (ACU)
Acme United Corp. (ACU)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -0.28 | -0.70 | 12.52 | 23.37 | 9.43 | 61.07 | 124.03 | 822.25 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 42.70 | |
| Open | 42.50 | |
| High | 43.07 | |
| Low | 41.94 | |
| Volume | 7,482 | |
| Change | -0.12 | |
| Change % | -0.28 | |
| Avg Volume (20 Days) | 11,569 | |
| Volume/Avg Volume (20 Days) Ratio | 0.65 | |
| 52 Week Range | 26.10 - 50.99 | |
| Price vs 52 Week High | -16.26% | |
| Price vs 52 Week Low | 63.60% | |
| Range | 0.47 | |
| Gap Up/Down | -0.32 | |
Fundamentals | ||
| Market Capitalization (Mln) | 158 | |
| EBIDTA | 18,656,106 | |
| PE Ratio | 8.1932 | |
| PEG Ratio | 1.4300 | |
| WallStreet Target Price | 53.00 | |
| Book Value | 27.1480 | |
| Earnings Per Share | 4.9700 | |
| EPS Estimate Current Quarter | 0.3600 | |
| EPS Estimate Next Quarter | 0.9400 | |
| EPS Estimate Current Year | 2.5300 | |
| EPS Estimate Next Year | 0.0000 | |
| Diluted EPS (TTM) | 4.9700 | |
| Revenues | ||
| Profit Marging | 0.0967 | |
| Operating Marging (TTM) | 0.0569 | |
| Return on asset (TTM) | 0.0535 | |
| Return on equity (TTM) | 0.2058 | |
| Revenue TTM | 190,618,944 | |
| Revenue per share TTM | 52.9590 | |
| Quarterly Revenue Growth (YOY) | -0.0190 | |
| Quarterly Earnings Growth (YOY) | 0.3950 | |
| Gross Profit (TTM) | 63,558,785 | |
| Dividends | ||
| Dividend Share | 0.5800 | |
| Dividend Yield | 0.0147 | |
| Valuations | ||
| Trailing PE | 8.1932 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.5825 | |
| Revenue Enterprise Value | 0.9194 | |
| EBITDA Enterprise Value | 5.6979 | |
| Shares | ||
| Shares Outstanding | 3,645,200 | |
| Shares Float | 3,189,516 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.02 | |
| Insider (%) | 12.56 | |
| Institutions (%) | 72.19 | |
08/16 10:05 EST - zacks.com
4 Stocks to Buy as Cooling Inflation Bolsters Rut Cut Hopes
Stocks like DoubleDown Interactive Co., Ltd. (DDI), Acme United Corporation (ACU), Traeger, Inc. (COOK) and Cinemark Holdings, Inc. (CNK) are likely to gain once the Fed starts its rate cuts.
4 Stocks to Buy as Cooling Inflation Bolsters Rut Cut Hopes
Stocks like DoubleDown Interactive Co., Ltd. (DDI), Acme United Corporation (ACU), Traeger, Inc. (COOK) and Cinemark Holdings, Inc. (CNK) are likely to gain once the Fed starts its rate cuts.
08/08 09:10 EST - zacks.com
Buy These 4 Stocks With Rising Cash Flows for Big Gains
Cash indicates a company's true financial health. It is the key to its existence, development and success.
Buy These 4 Stocks With Rising Cash Flows for Big Gains
Cash indicates a company's true financial health. It is the key to its existence, development and success.
07/29 10:40 EST - zacks.com
Is Acme United (ACU) Outperforming Other Consumer Discretionary Stocks This Year?
Here is how Acme United Corporation. (ACU) and iPower Inc. (IPW) have performed compared to their sector so far this year.
Is Acme United (ACU) Outperforming Other Consumer Discretionary Stocks This Year?
Here is how Acme United Corporation. (ACU) and iPower Inc. (IPW) have performed compared to their sector so far this year.
07/29 08:55 EST - zacks.com
4 Stocks to Boost Your Portfolio as Q2 GDP Grows at Solid Pace
Discretionary stocks like Acme United Corporation (ACU), PlayAGS, Inc. (AGS), Netflix, Inc. (NFLX) and Royal Caribbean Cruises Ltd. (RCL) are expected to benefit from the solid GDP growth.
4 Stocks to Boost Your Portfolio as Q2 GDP Grows at Solid Pace
Discretionary stocks like Acme United Corporation (ACU), PlayAGS, Inc. (AGS), Netflix, Inc. (NFLX) and Royal Caribbean Cruises Ltd. (RCL) are expected to benefit from the solid GDP growth.
07/29 07:00 EST - globenewswire.com
Acumen Pharmaceuticals Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug (ACU193) for Early Alzheimer's Disease
NEWTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) in the brain for the treatment of Alzheimer's disease (AD), today announced that the first subject has been dosed with a subcutaneous formulation of sabirnetug (ACU193) in a Phase 1 pharmacokinetic (PK) comparison study. The study plans to compare the PK between subcutaneous and intravenous administrations of sabirnetug in healthy volunteers.
Acumen Pharmaceuticals Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug (ACU193) for Early Alzheimer's Disease
NEWTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) in the brain for the treatment of Alzheimer's disease (AD), today announced that the first subject has been dosed with a subcutaneous formulation of sabirnetug (ACU193) in a Phase 1 pharmacokinetic (PK) comparison study. The study plans to compare the PK between subcutaneous and intravenous administrations of sabirnetug in healthy volunteers.
07/25 08:00 EST - seekingalpha.com
Acme United Q2: Seems Priced At A Decent Discount To Its Intrinsic Value
Acme United reported strong Q2 results with 8% organic sales growth, improved gross margins, and 29% increase in bottom line. The company's push into medical supplies is paying off, with recent acquisitions expanding product selection and customer base. Valuation shows ACU stock is trading at a decent discount to its intrinsic value, making it a good buy at current prices.
Acme United Q2: Seems Priced At A Decent Discount To Its Intrinsic Value
Acme United reported strong Q2 results with 8% organic sales growth, improved gross margins, and 29% increase in bottom line. The company's push into medical supplies is paying off, with recent acquisitions expanding product selection and customer base. Valuation shows ACU stock is trading at a decent discount to its intrinsic value, making it a good buy at current prices.
07/19 15:50 EST - seekingalpha.com
Acme United Corporation (ACU) Q2 2024 Earnings Call Transcript
Acme United Corporation (NYSE:ACU ) Q2 2024 Earnings Conference Call July 19, 2024 12:00 PM ET Company Participants Walter Johnsen - Chairman & CEO Paul Driscoll - CFO Conference Call Participants Tim Call - Capital Management Corporation Jeffrey Matthews - Ram Partners Operator Good day, and welcome to the Acme United Corporation's Q2 2024 Earnings. At this time, I would like to turn the call over to Walter Johnsen, Chairman and CEO.
Acme United Corporation (ACU) Q2 2024 Earnings Call Transcript
Acme United Corporation (NYSE:ACU ) Q2 2024 Earnings Conference Call July 19, 2024 12:00 PM ET Company Participants Walter Johnsen - Chairman & CEO Paul Driscoll - CFO Conference Call Participants Tim Call - Capital Management Corporation Jeffrey Matthews - Ram Partners Operator Good day, and welcome to the Acme United Corporation's Q2 2024 Earnings. At this time, I would like to turn the call over to Walter Johnsen, Chairman and CEO.
07/19 15:40 EST - globenewswire.com
CORRECTION – Acme United Reports 29% Increase in Net Income for Second Quarter of 2024
SHELTON, Conn., July 19, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Acme United Corporation (NYSE American: ACU), please note that in the "CONDENSED CONSOLIDATED STATEMENTS OF INCOME" table, the "Net sales" figure for "Three Months Ended June 30, 2023" should be "53,336", not "55,336" as previously stated, due to a typographical error. No other numbers or calculations were affected. The net sales figure for the three months ended June 30, 2023, was correctly stated as $53.3 million in the opening paragraph of the original release. The corrected release follows:
CORRECTION – Acme United Reports 29% Increase in Net Income for Second Quarter of 2024
SHELTON, Conn., July 19, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Acme United Corporation (NYSE American: ACU), please note that in the "CONDENSED CONSOLIDATED STATEMENTS OF INCOME" table, the "Net sales" figure for "Three Months Ended June 30, 2023" should be "53,336", not "55,336" as previously stated, due to a typographical error. No other numbers or calculations were affected. The net sales figure for the three months ended June 30, 2023, was correctly stated as $53.3 million in the opening paragraph of the original release. The corrected release follows:
07/19 11:15 EST - zacks.com
Acme United Corporation. (ACU) Q2 Earnings Top Estimates
Acme United Corporation. (ACU) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.94 per share.
Acme United Corporation. (ACU) Q2 Earnings Top Estimates
Acme United Corporation. (ACU) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.94 per share.
07/19 09:00 EST - globenewswire.com
Acme United Reports 29% Increase in Net Income for Second Quarter of 2024
SHELTON, Conn., July 19, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended June 30, 2024 were $55.4 million compared to $53.3 million in the second quarter of 2023, an increase of 4%. Excluding the impact of the Camillus and Cuda hunting and fishing product lines sold on November 1, 2023, net sales for the second quarter of 2024 increased 8% compared to the second quarter of 2023. Net sales for the six months ended June 30, 2024 were $100.4 million, compared to $99.2 million in the same period in 2023, an increase of 1%. Excluding Camillus and Cuda, net sales for the six months increased 5% compared to the same period in 2023.
Acme United Reports 29% Increase in Net Income for Second Quarter of 2024
SHELTON, Conn., July 19, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended June 30, 2024 were $55.4 million compared to $53.3 million in the second quarter of 2023, an increase of 4%. Excluding the impact of the Camillus and Cuda hunting and fishing product lines sold on November 1, 2023, net sales for the second quarter of 2024 increased 8% compared to the second quarter of 2023. Net sales for the six months ended June 30, 2024 were $100.4 million, compared to $99.2 million in the same period in 2023, an increase of 1%. Excluding Camillus and Cuda, net sales for the six months increased 5% compared to the same period in 2023.
07/11 14:01 EST - globenewswire.com
Acme United to Release Second Quarter 2024 Financial Results on July 19, 2024
SHELTON, Conn., July 11, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) will release its financial results for Second Quarter 2024 on Friday, July 19, 2024, at 9:00 AM Eastern Time.
Acme United to Release Second Quarter 2024 Financial Results on July 19, 2024
SHELTON, Conn., July 11, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) will release its financial results for Second Quarter 2024 on Friday, July 19, 2024, at 9:00 AM Eastern Time.
06/13 10:10 EST - globenewswire.com
Acme United Corporation Board Approves Cash Dividend
SHELTON, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Acme United Corporation (NYSE American: ACU) declared a cash dividend of 15 cents per share on its outstanding common stock. The dividend is payable on July 23, 2024, to stockholders of record on the close of business on July 2, 2024.
Acme United Corporation Board Approves Cash Dividend
SHELTON, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Acme United Corporation (NYSE American: ACU) declared a cash dividend of 15 cents per share on its outstanding common stock. The dividend is payable on July 23, 2024, to stockholders of record on the close of business on July 2, 2024.
05/23 16:46 EST - globenewswire.com
Acme United Corporation Acquires the Assets of Elite First Aid
SHELTON, Conn., May 23, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that it has acquired the assets of Elite First Aid, Inc., a leading supplier of tactical, trauma and emergency response products.
Acme United Corporation Acquires the Assets of Elite First Aid
SHELTON, Conn., May 23, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that it has acquired the assets of Elite First Aid, Inc., a leading supplier of tactical, trauma and emergency response products.
05/17 09:00 EST - globenewswire.com
Acme United Corporation to Present at the Singular Research Spring Select Webinar on May 22, 2024
SHELTON, Conn., May 17, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) will present at the Singular Research Spring Select Webinar on Wednesday, May 22, 2024 at 4:30 pm ET/1:30 pm PT.
Acme United Corporation to Present at the Singular Research Spring Select Webinar on May 22, 2024
SHELTON, Conn., May 17, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) will present at the Singular Research Spring Select Webinar on Wednesday, May 22, 2024 at 4:30 pm ET/1:30 pm PT.
04/20 12:21 EST - seekingalpha.com
Acme United: The Past Year Worked Out Well, An Upgrade Is Warranted
ACME United has shown improvements in margins and profitability, leading to a change in the rating from hold to buy. The company's debt has decreased, and its interest coverage ratio is healthy, indicating no risk of insolvency. ACME United's recent acquisition and expansion efforts suggest potential for growth in the upcoming quarters.
Acme United: The Past Year Worked Out Well, An Upgrade Is Warranted
ACME United has shown improvements in margins and profitability, leading to a change in the rating from hold to buy. The company's debt has decreased, and its interest coverage ratio is healthy, indicating no risk of insolvency. ACME United's recent acquisition and expansion efforts suggest potential for growth in the upcoming quarters.
04/19 15:13 EST - seekingalpha.com
Acme United Corporation (ACU) Q1 2024 Earnings Call Transcript
Acme United Corporation (ACU) Q1 2024 Earnings Call Transcript
Acme United Corporation (ACU) Q1 2024 Earnings Call Transcript
Acme United Corporation (ACU) Q1 2024 Earnings Call Transcript
04/19 09:00 EST - globenewswire.com
Acme United Reports 39% Increase in Earnings Per Share for First Quarter of 2024
SHELTON, Conn., April 19, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended March 31, 2024 were $45.0 million compared to $45.8 million for the quarter ended March 31, 2023, a decrease of 2%. Excluding the impact of the Camillus and Cuda hunting and fishing product lines sold on November 1, 2023, sales for the first quarter of 2024 increased 1% compared to the first quarter of 2023.
Acme United Reports 39% Increase in Earnings Per Share for First Quarter of 2024
SHELTON, Conn., April 19, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended March 31, 2024 were $45.0 million compared to $45.8 million for the quarter ended March 31, 2023, a decrease of 2%. Excluding the impact of the Camillus and Cuda hunting and fishing product lines sold on November 1, 2023, sales for the first quarter of 2024 increased 1% compared to the first quarter of 2023.
04/12 11:34 EST - globenewswire.com
Acme United to Release First Quarter 2024 Financial Results on April 19, 2024
SHELTON, Conn., April 12, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) will release its financial results for First Quarter 2024 on Friday, April 19, 2024, at 9:00 a.m. Eastern Time.
Acme United to Release First Quarter 2024 Financial Results on April 19, 2024
SHELTON, Conn., April 12, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) will release its financial results for First Quarter 2024 on Friday, April 19, 2024, at 9:00 a.m. Eastern Time.
03/26 09:00 EST - newsfilecorp.com
Acme United Corporation to Present at The LD Micro Invitational XIV
Presentation on Tuesday, April 9 at 3:00 PM ET Shelton, Connecticut--(Newsfile Corp. - March 26, 2024) - Acme United Corporation (NYSE American: ACU) announced today that it will present at the 14th Annual LD Micro Invitational, to be held at the Sofitel New York on April 8-9, 2024. Walter C. Johnsen, Chairman and CEO, will present on Tuesday, April 9, at 3:00 PM ET.
Acme United Corporation to Present at The LD Micro Invitational XIV
Presentation on Tuesday, April 9 at 3:00 PM ET Shelton, Connecticut--(Newsfile Corp. - March 26, 2024) - Acme United Corporation (NYSE American: ACU) announced today that it will present at the 14th Annual LD Micro Invitational, to be held at the Sofitel New York on April 8-9, 2024. Walter C. Johnsen, Chairman and CEO, will present on Tuesday, April 9, at 3:00 PM ET.